Reviva Pharmaceuticals' (RVPH.O) lead experimental drug to treat adults with schizophrenia helped reduce severity of disease symptoms in a late-stage study, sending the company's shares up nearly 8% on Monday.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,